Skip to main content
. Author manuscript; available in PMC: 2022 Mar 16.
Published in final edited form as: Circulation. 2021 Jan 12;143(11):1139–1156. doi: 10.1161/CIRCULATIONAHA.120.047420

Table 1:

Patient Characteristics

Variables Control (n=11) ICM (n=20) p-value
Race/Ethnicity
White/Not Hispanic or Latino, n (%) 9 (82) 16 (80) 0.99
Other, n (%) 2 (18) 4 (20)
Male sex, n (%) 6 (55) 12 (60) 0.77
Age at Tissue Acquisition, years 44±4 52±3 0.15
Height, cm 169±3 170±2 0.86
Weight, kg 78±5 81±4 0.59
BMI, kg/m2 27.2±2.0 28.0±1.2 0.71
BSA, m2 1.9±0.1 1.9±0.0 0.59
Pre-Tissue Acquisition Echocardiographic Measurements
LVEF, % 65±3 22±3 <0.0001
LVEDD, cm 4.1±0.2 6.5±0.3 <0.0001
LVEDD index, cm/m2 2.2±0.1 3.4±0.2 <0.0001
LVESD, cm 2.8±0.2 5.8±0.4 <0.0001
LVESD index, cm/m2 1.5±0.1 3.1±0.2 <0.0001
Pre-Tissue Acquisition Hemodynamic Measurements
Systolic Blood Pressure, mmHg 119±6 109±4 0.14
Diastolic Blood Pressure, mmHg 68±3 70±2 0.73
Mean Right Atrial Pressure, mmHg 11±2 9±1 0.36
Cardiac Index, L/min/m2 3.9±0.4 2.0±0.1 <0.001
Pre-Tissue Acquisition Laboratory Values
Sodium, mmol/L 150±3 138±1 0.006
Creatinine, mg/dL 1.3±0.2 1.1±0.1 0.45
Hemoglobin, g/dL 9.4±0.5 12.8±0.5 <0.001

Characteristics of healthy heart donors and end-stage ischemic cardiomyopathy heart donors included in the study. Data are shown as mean ± standard error. Control vs ICM were compared using t-test for quantitative data and Fisher’s exact test for categorical data.